Studies using cell lines and human prostate tumor samples confirmed the underexpression of miR-99a in PC, and showed that the reduction in miR-99a provides a growth advantage for AR-positive PC cells under an androgen-depleted condition [89,90]. The gene discussed is AR; the disease is prostate neoplasm.